SPECIAL NOTICE

We are working on upgrading our websites and despite our best endeavours have experienced census type calamities for almost a week now. Our apologies, we hope to have all problems resolved by Monday August 15th.

InvestoGain Australia

Celebrating 20 Years in Business

Thank you for being part of our development since September 2001. With your ongoing support we look forward to many exciting developments ahead.

SEARCH LISTED COMPANY


Any AUS or NZ company

BROWSE

Browse Australian listed companies

0-9A B C D E F G H I J K L M N O P Q R S T U V W XY Z

Browse current Australian managed funds

0-9A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

SEARCH PRIVATE COMPANY


SEARCH FUNDS

Find any Australian or New Zealand company or fund (dead or alive) by using SEARCH above or go directly to the site:

APOLLO CONSOLIDATED LIMITED(AOP)

Click here for free access to this company's:
ASX, Legal & CGT Status

Former (or subsequent) names

Shareholder links

Our website ranking of AOP: rating 4
(4 out of 5)
COMPANY WEBSITE:

 

REGISTRY:

Computershare, Level 11, 172 St Georges Terrace, Perth WA 6000

Tel : +61 (0)3 9415 4000 or 1300 850 505 (within Australia)
Fax : +61 3 9473 2500
RegistryWebsite RegistryEmail

Company details

ISIN: AU000000AOP2
Address: 1202 Hay Street West Perth, WA 6005
Tel:  +61 (0) 8 6319 1900 Fax: +61 (0) 8 6314 1557

Date first listed: 29/06/2005
Company Secretary: Alex Neuling
Sector: Materials Industry Group: XMJ
Activities: The Company develops and markets a range of over the counter (OTC) skin care products

News & Events

Expand this box to read and print

Apollo Consolidated Limited (the "Company") will be reinstated to official quotation as from the commencement of trading on Wednesday, 11 April 2012, following the Company" compliance with listing rule 11.1.3 and chapters 1 and 2 of the ASX listing rules

10/04/2012

releases Half Year Accounts

14/03/2012

lodges third Supplementary Prospectus

01/03/2012

lodges second Supplementary Prospectus dated 27 February 2012

27/02/2012

issues supplementary prospectus

21/02/2012

releases a prospectus inviting applications for 10,000,000 Shares at an issue price of $0.20 per Share to raise $2,000,000. The Company may accept oversubscriptions of up to a further 2,500,000 Shares at an issue price of $0.20 per Share to raise up to a further $500,000

08/02/2012

reports that during the December quarter, the company moved toward finalisation of the Aspire Cote d'Ivoire transaction as announced to ASX on September 6, 2011 At a general meeting held on December 23, 2011, shareholders voted overwhelmingly to approve the Transaction and to change the nature of the activities of the company to focus on gold exploration at its Ivorian projects and on the advanced Rebecca Project.

01/02/2012

releases a shareholder presentation

24/01/2012

company advises that it has appointed BBY Limited (BBY) as sponsoring broker to the Company's offer of 10,000,000 new fully paid ordinary shares at an issue price of $0.20 per share (Offer) to raise up to $2,000,000 (before costs). Under the terms of the Offer, which is not underwritten, the Company may also accept oversubscriptions of up to 2,500,000 further shares at $0.20 per share to raise an additional $500,000

24/01/2012

we understand that on or about this date the company consolidated its shares 1 for 30

31/12/2011

all resolutions considered at the General Meeting were passed on a show of hands - trading in the Company's securities will remain suspended pending compliance with Chapters 1 & 2 of the Listing Rules, including lodgement of a prospectus (Prospectus) and completion of the placement of shares approved by the meeting (Placement). Preparation of the Prospectus is well advanced and it is now expected that this will be lodged in mid-January 2012

23/12/2011

the securities of Apollo Consolidated Limited (the "Company") will be suspended from official quotation from the commencement of trading on Friday 23 December 2011, pending the outcome of a resolution at the Company's general meeting to approve a change in the nature of the Company's activities. The Company's securities will remain suspended pending compliance with Chapters 1 and 2 of the Listing Rules

22/12/2011

Apollo Consolidated reported negative cash flow of $93,000 for quarter ended 30 September 2011. Operating cash flow for the period was $(83,000). Investing cash flow was $(10,000). Financing cash flow was nil. Cash in hand at the end of the quarter was $1.4m

17/10/2011

the securities of Apollo Consolidated Limited (the "Company") will be suspended from quotation immediately, following the announcement of the Company's proposed change of activities and its recompliance with chapters 1 and 2 of the Listing Rules

06/09/2011

the suspension of trading in the securities of Apollo Consolidated Limited (the "Company") will be lifted before the commencement of trading on Wednesday, 7 September 2011, following the announcement by the Company of its proposed change of activities and its re-compliance with chapters 1 and 2 of the Listing Rules

06/09/2011

securities reinstated to quotation

07/10/2009

releases Half Year Accounts to 31 December 2008

06/10/2009

offers under the Company's prospectus dated 4 September 2009 ("Prospectus") have closed, oversubscribed. Shares have now been allotted and Apollo's directors resolved to accept the maximum number of oversubscriptions permitted under the Prospectus General Offer, being an additional 120,000,000 shares

05/10/2009

the deed of company arrangement has been effectuated and control of the company reverts to its directors

02/10/2009

issues a supplementary prospectus

30/09/2009

name changed from Apollo Life Sciences Limited

09/09/2009
OFX Transferring Money Internationally to Free

 

Click here for free access to this company's:
ASX, Legal & CGT Status

Your comments

Please read our Terms before viewing comments.

 

Company Updates

Post your comments here

Please read our Terms before posting comments.
OMISSIONS
    You can post a comment here about this company

    Please click in the "I'm not a robot" box and enter the word/figures you see in the image that then appears.

    loading Posting your comments. Please wait...

     


     

    Click here for free access to this company's:
    ASX, Legal & CGT Status

    Directors' on-market share transactions (last 5)

    rss feeds

    Purchases Sales

    DATEDIRECTORNUMBERPRICEAMOUNT
    18/04/2018Anthony James75,000$0.260$19,500
    19/03/2018Stephen West-300,000$0.250$75,000
    05/07/2012Nick Castleden200,000$0.100$20,000

    Click here for the last 20 transactions all companies

    Directors & Executives (current)

    NAMETITLEDATE OF APPT
    Roger SteinepreisChairman04/08/2009
    Nick CastledenManaging Director, CEO04/08/2009
    Robert GherghettaNon Exec Director16/04/2012
    Anthony JamesNon Exec Director18/04/2018

    Date of first appointment, title may have changed.

    Directors & Executives (former)

    NAMETITLEDATE OF APPOINTMENTDATE OF RESIGNATION
    George VentourasNon Exec Director04/08/200902/10/2018
    Stephen WestNon Exec Director16/04/201218/04/2018
    John PriestCEO12/09/200204/08/2009
    Antony BastenNon Exec Director21/04/200404/08/2009
    Paul MurnaneNon Exec Director22/04/200404/08/2009
    Jane CraigCOO20/06/200301/05/2008
    Bill MossNon Exec Director07/03/200603/10/2007
    Greg Russell-JonesScientific Director 26/05/200619/07/2007
    Garry KaanCFO12/12/200625/05/2007
    Alan WattsNon Exec Director21/04/200421/07/2006

    Date of first appointment, title may have changed.